Oral vaccination with Salmonella enterica as a cruzipain-DNA delivery system confers protective immunity against Trypanosoma cruzi

Infection and Immunity

Volumn 76, Issue 1, 2008, Pages 324-333

  Cazorla, Silvia I ^a   Becker, Pablo D ^b   Frank, Fernanda M ^a   Ebensen, Thomas ^b   Sartori, María J ^c   Corral, Ricardo S ^d   Malchiodi, Emilio L ^a   Guzmán, Carlos A ^b  

^a UNIVERSIDAD DE BUENOS AIRES   (Argentina)

^b HELMHOLTZ CENTRE FOR INFECTION RESEARCH   (Germany)

^c FACULTAD DE CIENCIAS MÉDICAS   (Argentina)

^d HOSPITAL DE NIÑOS RICARDO GUTIÉRREZ   (Argentina)

Author keywords

[No Author keywords available]

Indexed keywords

ASPARTATE AMINOTRANSFERASE; CD4 ANTIGEN; CD8 ANTIGEN; CPG OLIGODEOXYNUCLEOTIDE; CREATINE KINASE; CRUZIPAIN; GAMMA INTERFERON; GRANULOCYTE MACROPHAGE COLONY STIMULATING FACTOR; IMMUNOGLOBULIN A; INTERLEUKIN 2; LACTATE DEHYDROGENASE; MACROPHAGE ACTIVATING LIPOPEPTIDE 2; RECOMBINANT PROTEIN;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; CD4+ T LYMPHOCYTE; CD8+ T LYMPHOCYTE; CELL PROLIFERATION; CHAGAS DISEASE; CONTROLLED STUDY; DELAYED HYPERSENSITIVITY; DISEASE MODEL; DRUG EFFECT; DRUG EFFICACY; FEMALE; GENE TARGETING; IMMUNOGLOBULIN BLOOD LEVEL; INFECTION PREVENTION; INTESTINE LYMPHATIC TISSUE; MOUSE; MUCOSAL IMMUNITY; MUSCLE INJURY; MYCOPLASMA FERMENTANS; NONHUMAN; PARASITEMIA; PRIORITY JOURNAL; SALMONELLA ENTERICA; SALMONELLA ENTERICA TYPHIMURIUM; SPLEEN CELL; TRYPANOSOMA CRUZI; TRYPOMASTIGOTE; VACCINATION;

ADMINISTRATION, ORAL; ANIMALS; CHAGAS DISEASE; CYSTEINE ENDOPEPTIDASES; FEMALE; MICE; MICE, INBRED C3H; PARASITEMIA; PROTOZOAN VACCINES; SALMONELLA ENTERICA; TH1 CELLS; TRYPANOSOMA CRUZI; VACCINES, DNA;

EID: 37749054376     PISSN: 00199567     EISSN: None     Source Type: Journal    
DOI: 10.1128/IAI.01163-07     Document Type: Article

References (54)

1. Aliberti, J. C., J. T. Souto, A. P. Marino, J. Lannes-Vieira, M. M. Teixeira, J. Farber, R. T. Gazzinelli, and J. S. Silva. 2001. Modulation of chemokine production and inflammatory responses in interferon-gamma- and tumor necrosis factor-R1-deficient mice during Trypanosoma cruzi infection. Am. J. Pathol. 58:1433-1440.
2. +-T-cell-dependent control of Trypanosoma cruzi infection in a highly susceptible mouse strain after immunization with recombinant proteins based on amastigote surface protein 2. Infect. Immun. 73:6017-6025.
3. Bellotti, G., E. A. Bocchi, A. V. de Moraes, M. L. Higuchi, M. Barbero-Marcial, E. Sosa, A. Esteves-Filho, R. Kalil, R. Weiss, A. Jatene, and F. Pileggi. 1996. In vivo detection of Trypanosoma cruzi antigens in hearts of patients with chronic Chagas' heart disease. Am. Heart J. 131:301-307.
4. Beyer, T., M. Hermann, C. Reiser, W. Bertling, and J. Hess. 2001. Bacterial carriers and virus-like-particles as antigen delivery device: role of dendritic cells in antigen presentation. Curr. Drug Targets Infect. Disord. 1:287-302.
5. Bontempi, E., and J. J. Cazzulo. 1990. Digestion of human immunoglobulin G by the major cysteine proteinase (cruzipain) from Trypanosoma cruzi. FEMS Microbiol. Lett. 58:337-341.
6. Borsutzky, S., K. Kretschmer, P. D. Becker, P. F. Muhlradt, C. J. Kirschning, S. Weiss, and C. A. Guzman. 2005. The mucosal adjuvant macrophage-activating lipopeptide-2 directly stimulates B lymphocytes via the TLR2 without the need of accessory cells. J. Immunol. 174:6308-6313.
7. Borsutzky, S., V. Fiorelli, T. Ebensen, A. Tripiciano, F. Rharbaoui, A. Scoglio, C. Link, F. Nappi, M. Morr, S. Butto, A. Cafaro, P. F. Muhlradt, B. Ensoli, and C. A. Guzman. 2003. Efficient mucosal delivery of the HIV-1 Tat protein using the synthetic lipopeptide MALP-2 as adjuvant. Eur. J. Immunol. 33:1548-1556.
8. Brandariz, S., A. Schijman, C. Vigliano, P. Arteman, R. Viotti, C. Beldjord, and M. J. Levin. 1995. Detection of parasite DNA in Chagas' heart disease. Lancet 346:1370-1371.
9. Campetella, O., J. Henriksson, L. Aslund, A. C. Frasch, U. Pettersson, and J. J. Cazzulo. 1992. The major cysteine proteinase (cruzipain) from Trypanosoma cruzi is encoded by multiple polymorphic tandemly organized genes located on different chromosomes. Mol. Biochem. Parasitol. 50:225-234.
10. Carbonetto, C. H., E. L. Malchiodi, M. Chiaramonte, E. L. Durante de Isola, C. A Fossati, and R. A. Margni. 1990. Isolation of a Trypanosoma cruzi antigen by affinity chromatography with a monoclonal antibody. Preliminary evaluation of its possible applications in serological tests. Clin. Exp. Immunol. 82:93-96.
11. Chu, R. S., O. S. Targoni, A. M. Krieg, P. V. Lehmann, and C. V. Harding. 1997. CpG oligodeoxynucleotides act as adjuvants that switch on T helper 1 (Th1) immunity. J. Exp. Med. 186:1623-1631.
12. Darji, A., C. A. Guzman, B. Gerstel, P. Wachholz, K. N. Timmis, J. Wehland, T. Chakraborty, and S. Weiss. 1997. Oral somatic transgene vaccination using attenuated Salmonella typhimurium. Cell 91:765-775.
13. Darji, A., S. zur Lage, A. I. Garbe, T. Chakraborty, and S. Weiss. 2000. Oral delivery of DNA vaccines using attenuated Salmonella typhimurium as carrier. FEMS Immunol. Med. Microbiol. 27:341-349.
14. Dietrich, G., S. Spreng, D. Favre, J. F. Viret, and C. A. Guzman. 2003. Live attenuated bacteria as vectors to deliver plasmid DNA vaccines. Curr. Opin. Mol. Ther. 5:10-19.
15. Ebensen, T., S. Paukner, C. Link, P. Kudela, C. de Domenico, W. Lubitz, and C. A. Guzman. 2004. Bacterial ghosts are an efficient delivery system for DNA vaccines. J. Immunol. 172:6858-6865.
16. Fralish, B. H., and R. L. Tarleton. 2003. Genetic immunization with LYT1 or a pool of trans-sialidase genes protects mice from lethal Trypanosoma cruzi infection. Vaccine 21:3070-3080.
17. Frank, F. M., P. B. Petray, S. I. Cazorla, M. C. Muñoz, R. S. Corral, and E. L. Malchiodi. 2003. Use of a purified Trypanosoma cruzi antigen and CpG oligodeoxynucleotides for immunoprotection against a lethal challenge with trypomastigotes. Vaccine 22:77-86.
18. Garg, N., and R. L. Tarleton. 2002. Genetic immunization elicits antigen-specific protective immune responses and decreases disease severity in Trypanosoma cruzi infection. Infect. Immun. 70:5547-5555.
19. Garmony, H. S., R. W. Titball, K. A. Brown, and A. M. Benett. 2002. Construction and evaluation of eukariotic expression plasmid for stable delivery using attenuated Salmonella. Microb. Pathogen. 34:115-119.
20. Garmory, H. S., K. F. Griffin, K. A. Brown, and R. W. Titball. 2003. Oral immunisation with live aroA attenuated Salmonella enterica serovar Typhimurium expressing the Yersinia pestis V antigen protects mice against plague. Vaccine 21:3051-3057.
21. Gazzinelli, R. T., I. P. Oswald, S. Hieny, S. L. James, and A. Sher. 1992. The microbicidal activity of IFN-γ-treated macrophages against Trypanosoma cruzi involves an L-arginine-dependent, NO-mediated mechanism inhibitable by IL-10 and TGF-β. Eur. J. Immunol. 22:2501-2506.
22. Gentschev, I., J. Fensterle, A. Schmidt, T. Potapenko, J. Troppmair, W. Goebel, and U. R. Rapp. 2005. Use of a recombinant Salmonella enterica serovar Typhimurium strain expressing C-Raf for protection against C-Raf induced lung adenoma in mice. BMC Cancer 5:15.
23. Guzman-Bracho, C. 2001. Epidemiology of Chagas disease in Mexico: an update. Trends Parasitol. 17:372-376.
24. Hemmi, H., O. Takeuchi, T. Kawai, T. Kaisho, S. Sato, H. Sanjo, M. Matsumoto, K. Hoshino, H. Wagner, K. Takeda, and S. Akira. 2000. A Toll-like receptor recognizes bacterial DNA. Nature 408:740-745.
25. Hoiseth, S. K., and B. A. Stocker. 1981. Aromatic-dependent Salmonella typhimurium are non-virulent and effective as live vaccines. Nature 291:238-239.
26. Krautz, G. M., J. C. Kissinger, and A. U. Krettli. 2000. The targets of the lytic antibody response against Trypanosoma cruzi. Parasitol. Today 16:31-34.
27. Krieg, A. M., A. K. Yi., S. Matson, T. J. Waldschmidt, G. A. Bishop, R. Teasdale, G. A. Koretzky, and D. M. Klinman. 1995. CpG motifs in bacterial DNA trigger direct B-cell activation. Nature 374:546-549.
28. Kwon, Y. M., M. M. Cox, and L. N. Calhoun. 2007. Salmonella-based vaccines for infectious diseases. Expert. Rev. Vaccines 6:147-152.
29. Laguens, R. P., P. M. Cossio, C. Diez, A. Segal, C. Vasquez, E. Kreutzer, E. Khoury, and R. M. Arana. 1975. Immunopathologic and morphologic studies of skeletal muscle in Chagas' disease. Am. J. Pathol. 80:153-162.
30. Lane, J. E., D. Olivares-Villagomez, C. L. Vnencak-Jones, T. L. McCurley, and C. E. Carter. 1997. Detection of Trypanosoma cruzi with the polymerase chain reaction and in situ hybridization in infected murine cardiac tissue. Am. J. Trop. Med. Hyg. 5:588-595.
31. Laucella, S. A., M. Postan, D. Martin, B. Hubby Fralish, M. C. Albareda, M. G. Alvarez, B. Lococo, G. Barbieri, R. J. Viotti, and R. L. Tarleton. 2004. Frequency of IFN-γ-producing T cells specific for Trypanosoma cruzi inversely correlates with disease severity in chronic human Chagas disease. J. Infect. Dis. 189:909-918.
32. Loise, S., C. Le Gall, L. Doucet, C. Ferec, and V. Floch. 2001. Contribution of plasmid DNA to hepatotoxicity after systemic administration of lipoplexes. Hum. Gene Ther. 12:685-696.
33. + CTL. J. Immunol. 160:1817-1823.
34. Malchiodi, E. L., M. G. Chiaramonte, N. J. Taranto, N. W. Zwirner, and R. A. Margni. 1994. Cross reactivity studies and differential serodiagnosis of Trypanosoma cruzi and Leishmania spp. human infection. Use of immunoblotting and ELISA with a purified antigen (Ag 163B6). Clin. Exp. Immunol. 97:417-423.
35. Mirkin, G. A., A. M. Celentano, E. L. Malchiodi, M. Jones, and S. M. Gonzalez Cappa. 1997. Different Trypanosoma cruzi strains promote neuromyopathic damage mediated by distinct T lymphocyte subsets. Clin. Exp. Immunol. 107:328-334.
36. Motameni, A. R., I. J. Juncadella, S. K. Ananthanarayanan, M. N. Hedrick, Y. Huet-Hudson, and J. Anguita. 2004. Delivery of the immunosuppressive antigen Salp15 to antigen-presenting cells by Salmonella enterica serovar Typhimurium aroA mutants. Infect. Immun. 72:3638-3642.
37. Mühlradt, P. F., M. Kiess, H. Meyer, R. Süssmuth, and G. Jung. 1997. Isolation, structure elucidation, and synthesis of a macrophage stimulatory lipopeptide from Mycoplasma fermentans acting at picomolar concentration. J. Exp. Med. 185:1951-1958.
38. Paglia, P., E. Medina, I. Arioli, C. A. Guzman, and M. P. Colombo. 1998. Gene transfer in dendritic cells, induced by oral DNA vaccination with Salmonella typhimurium, results in protective immunity against a murine fibrosarcoma. Blood 92:3172-3176.
39. Paglia, P., N. Terrazzini, K. Schulze, C. A. Guzman, and M. P. Colombo. 2000. In vivo correction of genetic defects of monocyte/macrophages using attenuated Salmonella as oral vectors for targeted gene delivery. Gene Ther. 7:1725-1730.
40. Parussini, F., V. G. Duschak., and J. J. Cazzulo. 1998. Membrane-bound cysteine proteinase isoforms in different developmental stages of Trypanosoma cruzi. Cell. Mol. Biol. (Noisy-le-grand) 44:513-519.
41. Rharbaoui, F., B. Drabner, S. Borsutzky, U. Winckler, M. Morr, B. Ensoli, P. F. Muhlradt, and C. A. Guzman. 2002. The Mycoplasma-derived lipopeptide MALP-2 is a potent mucosal adjuvant. Eur. J. Immunol. 32:2857-2865.
42. Roman, M., E. Martin-Orozco, J. S. Goodman, M. D. Nguyen, Y. Sato, A. Ronaghy, R. S. Kornbluth, D. D. Richman, D. A. Carson, and E. Raz. 1997. Immunostimulatory DNA sequences function as T helper-1-promoting adjuvants. Nat. Med. 3:829-831.
43. Sardinha, L. R., R. M. Elias, T. Mosca, K. R. Bastos, C. R. Marinho, M. R. D'Imperio Lima, and J. M. Alvarez. 2006. Contribution of NK, NK T, γδ T, and αβ T cells to the gamma interferon response required for liver protection against Trypanosoma cruzi. Infect. Immun. 74:2031-2042.
44. Schnapp, A. R., C. S. Eickhoff, J. Scharfstein, and D. F. Hoft. 2002. Induction of B- and T-cell responses to cruzipain in the murine model of Trypanosoma cruzi infection. Microbes Infect. 4:805-813.
45. Schnapp, A. R., C. S. Eickhoff, D. Sizemore, R. Curtiss III, and D. F. Hoft. 2002. Cruzipain induces both mucosal and systemic protection against Trypanosoma cruzi in mice. Infect. Immun. 70:5065-5074.
46. Souto-Padron, T., O. Campetella, J. J. Cazzulo, and W. De Souza. 1990. Cysteine proteinases in T. cruzi immunocytochemical localization and involvement in parasite-host cell interaction. J. Cell Sci. 96:485-490.
47. Stober, C. B., U. G. Lange, M. T. Roberts, A. Alcami, and J. M. Blackwell. 2005. IL-10 from regulatory T cells determines vaccine efficacy in murine Leishmania major infection. J. Immunol. 175:2517-2524.
48. Tarleton, R. L., and L. Zhang. 1999. Chagas disease etiology: autoimmunity or parasite persistence? Parasitol. Today 15:94-99.
49. Tarleton, R. L., B. H. Koller, A. Latour, and M. Postan. 1992. Susceptibility of beta 2-microglobulin-deficient mice to Trypanosoma cruzi infection. Nature 356:338-340.
50. Tarleton, R. L., L. Zhang, and M. O. Downs. 1997. "Autoimmune rejection" of neonatal heart transplants in experimental Chagas' disease is a parasite-specific response to infected host tissue. Proc. Natl. Acad. Sci. USA 94:3932-3937.
51. WHO. 1999. Twelfth programme report of the UNDP/World Bank/WHO Special Programme for Research and Training in Tropical Disease (TDR). World Health Organization, Geneva, Switzerland.
52. + TC1 responses. J. Immunol. 159:6120-6130.
53. Wizel, B., N. Garg, and R. L. Tarleton. 1998. Vaccination with trypomastigote surface antigen 1-encoding plasmid DNA confers protection against lethal Trypanosoma cruzi infection. Infect. Immun. 66:5073-5081.
54. Yang, X. L., W. C. Liu, W. W. Yang, D. Zhong, Y. H. Liu, J. D. Zhang, J. H. Jiang, and S. S. Li. 2005. Oral immunization of mice with vaccine of attenuated Salmonella typhimurium expressing Helicobacter pylori urease B subunit. Biomed. Environ. Sci. 18:411-418.